La última palabra en dosis mínima
Nenhuma Miniatura disponível
Data
2005-07-01
Autores
Fernandes, César Eduardo [UNESP]
De Azevedo, Lucía Helena
Stephan, Cristina
De Souza Ferreira, José Arnaldo
De Melo, Nilson Roberto
Peixoto, Sergio
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
In this article we rewiewed the indications of the low-dose hormone replacement therapy in post menopausal women. We evaluate the effects of this therapy on menopausal symptoms bone metabolism, cardiovascular risk and endometrial cancer. The low-dose hormone replacement therapy is satisfactory to relief menopausal symptoms and improves lipid profile preventing atherosclerosis. It does not increase the risk of hyperplasia or endometrial cancer when is associate with progestagens. The low dose hormone replacement therapy is also associate to improve bone mineral density but to have better comprehension about the effective action of the low dose hormone replacement therapy on bone, more studies evaluating the risk of fractures are necessary.
Descrição
Palavras-chave
Bone metabolism, Cardiovascular risk, Endometrial cancer, Low dose, Menopausal symptoms, gestagen, atherosclerosis, bone metabolism, cardiovascular risk, endometrium cancer, hormonal therapy, human, hyperplasia, low drug dose, menopausal syndrome, postmenopause, review
Como citar
Revista Iberoamericana de Revisiones en Menopausia, v. 7, n. 3, p. 13-19, 2005.